<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Al-Ali, Firas</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">How Safe is Intracranial Angioplasty and Stenting? Lessons Learned from 188 Interventions</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">18-19</style></pages><abstract><style  face="normal" font="default" size="100%">Results of the Warfarin—Aspirin Symptomatic Intracranial Disease [WASID; NCT00004728] study suggested that patients with stroke as their qualifying event and a 70% to 99% stenosed lesion had a 1-year stroke rate of 22.5%. The objective of a study was to compare the safety and efficacy of endovascular revascularization for intracranial atherosclerosis to determine if it is possible to reduce the risk of stroke that was seen in the WASID study.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>